SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-14-003223
Filing Date
2014-03-31
Accepted
2014-03-31 12:00:10
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2219298z10-k.htm 10-K 1248038
2 EX-4.3 a2219298zex-4_3.htm EX-4.3 260994
3 EX-10.1.1 a2219298zex-10_11.htm EX-10.1.1 98211
4 EX-31.1 a2219298zex-31_1.htm EX-31.1 7770
5 EX-31.2 a2219298zex-31_2.htm EX-31.2 7770
6 EX-32 a2219298zex-32.htm EX-32 4341
7 G566734.JPG g566734.jpg GRAPHIC 68338
8 G88761.JPG g88761.jpg GRAPHIC 117263
9 G55138.JPG g55138.jpg GRAPHIC 100700
10 G793425.JPG g793425.jpg GRAPHIC 96950
11 G328337.JPG g328337.jpg GRAPHIC 33374
12 G999426.JPG g999426.jpg GRAPHIC 31172
13 G6379.JPG g6379.jpg GRAPHIC 37787
  Complete submission text file 0001047469-14-003223.txt   2298332
Mailing Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36303 | Film No.: 14728624
SIC: 2834 Pharmaceutical Preparations